Advertisement
Screener

Twist Bioscience Corporation (TWST) Pre-Tax Margin

Twist Bioscience Corp Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Twist Bioscience Corp pre-tax margin for the quarter ending 2026-06-30 was -29.35%, a 236.97% decline year-over-year.
  • Twist Bioscience Corp pre-tax margin for the quarter ending 2026-03-31 was -39.72%, a change of 2.47% year-over-year.
  • Twist Bioscience Corp pre-tax margin for the quarter ending 2025-12-31 was -29.18%, a change of 6.33% year-over-year.
  • Twist Bioscience Corp pre-tax margin for the quarter ending 2025-09-30 was -27.15%, a change of 13.87% year-over-year.
  • Twist Bioscience Corp pre-tax margin for fiscal 2025 was -20.43%, a change of 46.08% from fiscal 2024.
  • Twist Bioscience Corp pre-tax margin for fiscal 2024 was -66.51%, a change of 16.50% from fiscal 2023.
  • Twist Bioscience Corp pre-tax margin for fiscal 2023 was -83.01%, a change of 29.13% from fiscal 2022.
  • Twist Bioscience Corp pre-tax margin for fiscal 2022 was -112.14%, a change of 4.26% from fiscal 2021.
Available history
2017-09-30 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2026-06-30-29.35%-$34.74M$118.38M
2026-03-31-39.72%-$43.98M$110.72M
2025-12-31-29.18%-$30.25M$103.7M
2025-09-30-27.15%-$26.88M$99.01M
2025-06-3021.43%$20.58M$96.06M
2025-03-31-42.19%-$39.15M$92.79M
2024-12-31-35.50%-$31.5M$88.71M
2024-09-30-41.02%-$34.75M$84.71M
2024-06-30-104.81%-$85.38M$81.46M
2024-03-31-59.95%-$45.15M$75.3M
2023-12-31-59.98%-$42.89M$71.5M
2023-09-30-69.41%-$46.47M$66.95M
2023-06-30-89.07%-$56.77M$63.74M
2023-03-31-97.18%-$58.48M$60.18M
2022-12-31-76.96%-$41.75M$54.24M
2022-09-30-88.69%-$50.82M$57.31M
2022-06-30-108.11%-$60.67M$56.11M
2022-03-31-126.37%-$60.82M$48.13M
2021-12-31-133.20%-$55.97M$42.02M
2021-09-30-107.77%-$40.9M$37.95M
2021-06-30-121.12%-$42.41M$35.02M
2021-03-31-121.32%-$37.86M$31.2M
2020-12-31-116.66%-$32.85M$28.16M
2020-09-30-74.17%-$24.06M$32.43M
2020-06-30-132.91%-$28.19M$21.21M
2020-03-31-164.31%-$31.71M$19.3M
2019-12-31-323.94%-$55.6M$17.16M
2019-09-30-197.42%-$31.07M$15.74M
2019-06-30-204.87%-$27.86M$13.6M
2019-03-31-190.67%-$25.85M$13.56M
2018-12-31-196.62%-$22.6M$11.49M
2018-09-30-234.64%-$19.73M$8.41M
2018-06-30-268.35%-$17.55M$6.54M
2018-03-31-272.95%-$16.83M$6.17M
2017-12-31-391.49%-$16.89M$4.31M

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-09-30-20.43%-$76.95M$376.57M
2024-09-30-66.51%-$208.17M$312.97M
2023-09-30-83.01%-$203.47M$245.11M
2022-09-30-112.14%-$228.27M$203.57M
2021-09-30-116.39%-$154.03M$132.33M
2020-09-30-154.88%-$139.55M$90.1M
2019-09-30-197.44%-$107.38M$54.39M
2018-09-30-279.21%-$70.99M$25.43M
2017-09-30-548.25%-$59.03M$10.77M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78